Wutah dodolan YoY sajrone rolas wulan kepungkur: Corcept Therapeutics Corp (CORT)

Logo grafis Corcept Therapeutics Corp (CORT)

Corcept Therapeutics (CORT) dominates the cortisol receptor modulation segment, possessing absolute pricing power. Sales volume growth compared to the same period last year over the past 12 months confirms this status, and 30.40 reflects the latest value of the metric. However, reliance on a single drug and the risk of generics create vulnerability. Stable demand for endocrine therapy currently provides the company with a reliable cash flow.

Wutah dodolan YoY sajrone rolas wulan kepungkur: Corcept (CORT) kanggo 11.02.2024 - 18.11.2026

Corcept Therapeutics Inc. (CORT) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
Analisis kabeh metrik perusahaan:Corcept Therapeutics
Produk seri Corcept Therapeutics Incorporated

Corcept Therapeutics (CORT) specializes in biopharmaceuticals, implementing "green chemistry" principles to optimize resources during drug synthesis. This indicator reflects revenue dynamics over the last twelve months relative to the same period last year. It is critical for investors to assess the sustainability of this growth as confirmation of market demand for the drugs. Analyzing the company's TTM annual revenue growth rate helps identify risks of asset overheating or capital stagnation.

Pesaing Corcept Therapeutics (CORT)

Ascendis (ASND) - Wutah pendapatan taun lumaku|MDGL - Wutah dodolan YoY sajrone rolas wulan kepungkur|RYTM: Wutah dodolan YoY sajrone rolas wulan kepungkur|AKRO: Wutah dodolan YoY (TTM)|MTSR - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur MoonLake Corp|Crinetics Corp (CRNX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur newamsterdampharma.com (NAMS)|Wutah pendapatan YoY sajrone 12 wulan kepungkur soleno.life SLNO|Wutah dodolan YoY (TTM) FOLD (amicusrx.com)|Wutah pendapatan taunan sajrone rolas wulan kepungkur 89bio (ETNB)|Agios - Wutah dodolan YoY (TTM)|Structure Corp - Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur|mimedx.com (MDXG) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah dodolan taun lumaku RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur MBX|Wutah dodolan YoY sajrone rolas wulan kepungkur Altimmune Pharma (ALT)|Wutah dodolan YoY sajrone rolas wulan kepungkur AARD (Aardvark Therapeutics Corp)|Wutah dodolan YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Wutah pendapatan taun lumaku|BMEA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|vTv Therapeutics, Inc. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Agape ATP Corp.|Wutah pendapatan YoY sajrone 12 wulan kepungkur Pluri (PLUR)|Wutah dodolan YoY (TTM) SYBX|Wutah pendapatan taunan sajrone rolas wulan kepungkur Lipocine Inc|Wutah dodolan YoY sajrone rolas wulan kepungkur Matinas BioPharma Holdings MTNB|Wutah pendapatan taunan sajrone rolas wulan kepungkur Spruce Biosciences (SPRB)|GLTO: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku CTCX|LUMO (Lumos Pharma) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY sajrone 12 wulan kepungkur ONVO|RDUS (Radius Pharmaceuticals) - Wutah dodolan YoY (TTM)